GL1X · GenesisL1 explorer

MolNFT v1 · #95193 · protein

Crystal structure of wild-type human transthyretin in complex with lumiracoxib

4IIZ: “Crystal structure of wild-type human transthyretin in complex with lumiracoxib”. X-ray diffraction, 1 ligand (LUR), 2 pockets (best druggability 0.35). MolNFT v1 #95193 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4IIZ
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
LUR
Pockets
2 · best druggability 0.35

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 51% strandP02766
BTransthyretinprotein1157% helix, 50% strandP02766

Ligands and binding sites

  • LUR · {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1660.350.7717empty
2630.300.7417empty

Interfaces

1 interface between chains.

  • A–B · 897 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 4IIZ · Crystal structure of wild-type human transthyretin in complex with lumiracoxib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.